{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:46:24Z","timestamp":1769607984280,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xpro.2025.103856","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:44:31Z","timestamp":1749239071000},"page":"103856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"6","author":[{"given":"Katsuhiko","family":"Kunitake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takami","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-7506","authenticated-orcid":false,"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2025.103856_bib1","article-title":"Phase 1\/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy","volume":"6","author":"Komaki","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xpro.2025.103856_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2025.103856_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.xpro.2025.103856_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xpro.2025.103856_bib5","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xpro.2025.103856_bib6","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/s41467-018-06206-0","article-title":"Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies","volume":"9","author":"Antoury","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2025.103856_bib7","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1038\/s41598-019-40421-z","article-title":"Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride","volume":"9","author":"Takizawa","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2025.103856_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/268163a0","article-title":"Transitory expression of Thy-1 antigen in skeletal muscle development","volume":"268","author":"Lesley","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2025.103856_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/289060a0","article-title":"Surface antigen differentiation during human myogenesis in culture","volume":"289","author":"Walsh","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2025.103856_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0006-8993(84)91083-7","article-title":"Muscles of adult rats and mice express the Thy-1 glycoprotein on denervation","volume":"308","author":"Booth","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.xpro.2025.103856_bib11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41598-024-52530-5","article-title":"Characterization of CD90\/Thy-1 as a crucial molecular signature for myogenic differentiation in human urine-derived cells through single-cell RNA sequencing","volume":"14","author":"Kunitake","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2025.103856_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/jcm9030827","article-title":"Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells","volume":"9","author":"Kim","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xpro.2025.103856_bib13","doi-asserted-by":"crossref","first-page":"W193","DOI":"10.1093\/nar\/gkab442","article-title":"eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping","volume":"49","author":"Chiba","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xpro.2025.103856_bib14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41467-025-56644-w","article-title":"Duchenne muscular dystrophy: recent insights in brain related comorbidities","volume":"16","author":"Vaillend","year":"2025","journal-title":"Nat. Commun."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616672500262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616672500262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:35:02Z","timestamp":1769560502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616672500262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S266616672500262X"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2025.103856","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2025.103856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101901","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103856"}}